Cite
Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin.
MLA
Zhenni Sun, et al. “Downregulation of NPM Expression by Her-2 Reduces Resistance of Gastric Cancer to Oxaliplatin.” Oncology Letters, vol. 13, no. 4, Apr. 2017, pp. 2377–84. EBSCOhost, https://doi.org/10.3892/ol.2017.5722.
APA
Zhenni Sun, Lu Yue, Zan Shen, Yong Li, Aihua Sui, Tianjun Li, Qian Tang, Ruyong Yao, & Yongning Sun. (2017). Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin. Oncology Letters, 13(4), 2377–2384. https://doi.org/10.3892/ol.2017.5722
Chicago
Zhenni Sun, Lu Yue, Zan Shen, Yong Li, Aihua Sui, Tianjun Li, Qian Tang, Ruyong Yao, and Yongning Sun. 2017. “Downregulation of NPM Expression by Her-2 Reduces Resistance of Gastric Cancer to Oxaliplatin.” Oncology Letters 13 (4): 2377–84. doi:10.3892/ol.2017.5722.